Drugs / MMC
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03048123 Comparator | Oct 2015 → Oct 2016 | hepatocellular carcinoma | Sun Yat-sen University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MMC | “lipiodol mixed with chemotherapy drugs (EADM, lobaplatin, and MMC)” NCT03048123 ↗ |
| Route | Other | “Hepatic intra-arterial infusion with lipiodol mixed with chemotherapy drugs (EADM, lobaplatin, and MMC)” NCT03048123 ↗ |